ADmit Therapeutics is a biotechnology company intended to develop a test for early diagnosis of Alzheimer.
ADmit Therapeutics was founded in 2017 by Marta Barrachina.
1282 health care and life sciences companies are in the directory, 186 of them in the same 1-10 employee range and 184 based in European Union (EU).
ADmit Therapeutics may be growing as it has successfully secured 5.4 million euros in a funding round. This capital injection indicates investor confidence and provides the financial resources necessary for further development and expansion. The company's ability to attract such funding suggests a positive trajectory in its operations within the biotechnology and health diagnostics industry.
“ADmit THERAPEUTICS - un test de diagnóstico precoz para la enfermedad de Alzheimer. DETECCIÓN EN LA PRÁCTICA CLÍNICA. ADmit Therapeutics, S.L.” admit-therapeutics.com
Founded in 2017, ADmit Therapeutics works in biotechnology, health care and health diagnostics from European Union (EU) and has 1-10 employees. It has raised $8 million over 5 rounds and its website drew about 67 visits in the latest month measured.
501-1,000 employees · apcerls.com
1-10 employees · aionlabs.com
1-10 employees · activsignal.com
1-10 employees · aeonbiopharma.com
1-10 employees · acurapharm.com
1-10 employees · acumensportsandshoulder.com
101-250 employees · dunnepharmacies.ie
51-100 employees · aoporphan.com
11-50 employees · advancells.com
11-50 employees · 8five8tx.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.